Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Nasdaq symbols : Itrm save search
Iterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule
Published: 2023-12-04 (Crawled : 13:00) - globenewswire.com
ITRM | $1.43 19K
|
Health Technology
|
| O: -1.89%
H: 5.77%
C: 1.44%
nasdaq therapeutics
Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-06-14 (Crawled : 14:20) - globenewswire.com
ITRM | $1.43 19K
|
Health Technology
|
| O: 6.15%
H: 7.48%
C: -3.27%
nasdaq grant therapeutics
Iterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule
Published: 2022-09-01 (Crawled : 14:20) - globenewswire.com
ITRM | $1.43 19K
|
Health Technology
|
| O: 1.15%
H: 0.38%
C: -7.58%
nasdaq therapeutics
Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-07-06 (Crawled : 21:00) - globenewswire.com
ITRM | $1.43 19K
|
Health Technology
|
| O: 2.71%
H: 4.78%
C: 2.55%
nasdaq grant therapeutics
Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-02-08 (Crawled : 23:00) - globenewswire.com
ITRM | $1.43 19K
|
Health Technology
|
| O: 4.76%
H: 3.61%
C: 0.0%
therapeutics nasdaq report grant granted
ITERUM THERAPEUTICS PLC (NASDAQ: ITRM) OCTOBER 4, 2021 INVESTOR FILING DEADLINE:
Published: 2021-09-27 (Crawled : 16:00) - prnewswire.com
ITRM | $1.43 19K
|
Health Technology
|
| O: -5.07%
H: 5.98%
C: 4.17%
nasdaq
Iterum Therapeutics Receives Approval to Transfer to Nasdaq Capital MarketTrading on Nasdaq Capital Market is expected to begin on December 23, 2020
Published: 2020-12-21 (Crawled : 00:00) - biospace.com/
ITRM | $1.43 19K
|
Health Technology
|
| O: -0.11%
H: 11.86%
C: 9.28%
approval nasdaq
Iterum Therapeutics Receives Approval to Transfer to Nasdaq Capital Market
Published: 2020-12-21 (Crawled : 22:03) - globenewswire.com
ITRM | $1.43 19K
|
Health Technology
|
| O: 5.42%
H: 4.85%
C: 0.97%
approval therapeutics nasdaq
Iterum Therapeutics Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Published: 2020-06-03 (Crawled : 15:40) - globenewswire.com
ITRM | $1.43 19K
|
Health Technology
|
| O: -0.62%
H: 2.48%
C: -7.45%
offering nasdaq
Iterum Therapeutics Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Published: 2020-06-30 (Crawled : 15:40) - globenewswire.com
ITRM | $1.43 19K
|
Health Technology
|
| O: -7.75%
H: 3.82%
C: -9.16%
offering nasdaq
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0606 68.33% 250M
|
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
PRTG | $0.285 18.75% 170K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.